Primo Biotechnology
Taipei
About Primo Biotechnology
Primo Biotechnology harnesses advanced molecular imaging and radiopharmaceutical science to provide precise clinical information via targeted radiopharmaceuticals. Primo Biotechnology aims to form a patient-centric healthcare model and establish doctor-patient relationships founded on trust towards conveying hope and happiness to all patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2025)
- Website: primobt.comen
- Phone: 886-2-2537-1160
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/primo-biotechnology-91751 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.